Articles

Page 3 of 19

Cost-efficacy analysis of the MONET trial using Spanish antiretroviral drug prices

Authors: JR Arribas, A Hill, I Garcia and A Anceau

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P235

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV-infected subjects

Authors: V Spagnuolo, L Galli, S Salpietro, C Vinci, F Cossarini, G Travi, A Rubinacci, G Mignogna, M Cernuschi, S Bossolasco, A Lazzarin and A Castagna

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P233

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Smoking prevalence, cessation rates and relapse rates in the Swiss HIV Cohort Study (SHCS)

Authors: M Huber, B Ledergerber, R Jaccard, L Elzi, H Furrer, B Hirschel, M Cavassini, E Bernasconi, P Schmid and R Weber

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P231

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Abstract withdrawn

Authors:

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P229

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Therapeutics designed to neutralize soluble HIV tat protein could preserve IL-7 signaling and CD8 T-cell function in HIV+ patients

Authors: EM Faller, SM Sugden and PA MacPherson

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P227

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
No effect of a single supratherapeutic dose of lersivirine, a next-generation NNRTI, on QTc interval in healthy subjects

Authors: M Vourvahis, R Wong, NM Ndongo, M O'Gorman and M Tawadrous

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P225

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the 'real-life setting' proves the concept

Authors: P Ingiliz, MJ Obermeier, L Weitner, C Cordes, A Moll, B Hintsche, F Schlote, S Köppe, C Mayr and A Baumgarten

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P202

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Increasing numbers of acute hepatitis C infections in HIV-infected MSM and high reinfection rates following SVR

Authors: HJ Stellbrink, CK Schewe, M Vogel and C Noah

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P200

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

Authors: B Conway, A Barrieshee, HK Tossonian, K Wight, S Jassemi, M Tong, E Knight, L Gallagher, F Duncan and S DeVlaming

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P199

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Enfuvirtide in therapy at patients with HIV-infection and tuberculosis

Authors: AV Kravchenko, AV Kuznetsova, OA Kozyrev, VA Lukyanova and VG Kanestri

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P197

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Generalized tuberculosis in HIV-infected patients with AIDS

Authors: VN Zimina, IA Vasilieva, AV Kravchenko and FA Batyrov

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P195

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Epidemiology of HIV-associated tuberculosis (TB) co-infection in Krasnoyarsk region, Russian Federation

Authors: TA Chaychuk, NU Gankina and OG Nikonova

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P193

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
The use of a darunavir/ritonavir once-daily regimen in two pregnant women

Authors: JS Lambert, LJ Else, V Jackson, L Dickinson, DJ Back, M Brennan, C Weldridge, S Coulter-Smith, S Gibbons and SH Khoo

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P189

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
BEST: Better Equipped to Start Treatment

Authors: J Bennett

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P166

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Pregnancy decisions and contraceptive use among HIV-positive women: a study in a large urban clinic in sub-Saharan Africa

Authors: J Walusimbi, E Birabwa, E Nabankema, A AnneMarie, I Lutalo and A Nakiwooga

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P164

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
A complex of measures effectiveness in reducing mother-to-child HIV transmission

Authors: SV Minaeva and GF Moshkovich

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P162

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Antiretroviral strategies for the treatment of pregnant HIV+ women and prevention of perinatal HIV transmission in Dodoma, Tanzania: AMANI Study

Authors: G Liuzzi, F Vairo, Z Chaula, B Nguhuni, E Nicastri, N Bevilacqua, A Cannas, MG Paglia and G Ippolito

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P160

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
High preterm delivery rates associated with initiation of HAART during pregnancy

Authors: GP Taylor, M Douglas and J Smith

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P158

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Audit of outcomes of early initiation of antiretroviral therapy in children admitted to the paediatric wards at Kilifi district hospital, Kenya

Authors: HM Nabwera, S Mwaringa, R Kimutai and JA Berkley

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P156

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Feasibility and effectiveness of combination antiretroviral therapy in HIV-infected infants in Pietermaritzburg, South Africa

Authors: D Van der Linden, S Purchase and NH McKerrow

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P154

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Analysis of major and minor IAS-USA PI mutations in the MONET trial of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs

Authors: F Pulido, JR Arribas, A Hill, Y van Delft and C Moecklinghoff

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P131

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Detection of HIV type 1 mutations on the pol region in untreated patients in Northern Vietnam: determination of drug resistance and subtypes

Authors: S Ranger-Rogez, M Al Jawhari, B Nguyen, N Pham Hong, T Tran Quoc, J Pascual, J Doll, M Harzic, G Viretto and P Weinbreck

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P127

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Transmitted drug resistance associated with transmission clusters in newly diagnosed antiretroviral-naïve patients in Northern Greece

Authors: L Skoura, S Metallidis, AJ Buckton, JL Mbisa, D Pilalas, E Papadimitriou, A Papoutsi, AB Haidich, D Valagouti, O Tsachouridou, ZA Antoniadou, P Kollaras, P Nikolaidis and N Malisiovas

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P125

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan

Authors: O Salami, A Buzu and C Nzeme

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P123

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Antiretroviral regimen complexity as a predictor of adherence

Authors: C Boyle, A Wilson, G Treacy, G Sheehan, J Lambert, C Meegan and P Mallon

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P121

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Changing HIV guidelines: how to communicate treatment start

Authors: J Fehr, D Nicca, W Langewitz, D Haerry and M Battegay

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P117

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Fracture risk in HIV and the need for guidelines: the Probono-1 Trial

Authors: B Peters, H Isohanni, S Tillet, F Ibrahim, G Hampson, FMK Williams, MEO Perry, A Duncan and A Wierzbicki

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P99

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Markers of bone turnover are elevated in patients on antiretrovirals independent of the substance used

Authors: RJ Piso, M Rothen, JP Rothen and M Stahl

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P97

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Toxic intracellular anabolite levels of tenofovir and didanosine causing a steep CD4-cell decline

Authors: E de Jong, ME Haverkort, R ter Heine, RS Jansen, JH Beijnen and MA van Agtmael

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P95

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Mesenteric fat thickness in a group of HIV patients on HAART

Authors: SS Lee, E Liu and KW To

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P72

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Alexithymia, an impairment of emotional cognitive processing, is a candidate risk factor for carotid artery plaque formation in HIV-infected patients

Authors: F Vadini, F Sozio, E Mazzotta, C Agostinone, T Ursini, A Agostinone, G Placido, LM Manzoli and G Parruti

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P70

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Nitric oxide protects against HIV gp120 endothelial injury

Authors: S Fiorucci, A Mencarelli, D Francisci, E Distrutti, B Renga and F Baldelli

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P68

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Low serum phosphate levels are related to increased cardiovascular risk in HIV-1 infected patients

Authors: P Grima, M Guido, R Chiavaroli, P Tundo and A Zizza

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P66

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Cardiovascular risk in patients visiting the Hadassah AIDS Center, Jerusalem

Authors: S Schulman, V Rotshild, K Olshtein Pops, M Korem, S Israel, M Hauzi and S Maayan

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P64

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Role of platelet activation in the cardiovascular complications associated with HIV infection: differential effect of abacavir versus tenofovir

Authors: D Francisci, E Falcinelli, B Belfiori, E Petito, M Mezzasoma, F Baldelli and P Gresele

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P62

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
A comparison of the FDA TLOVR and FDA Snapshot algorithms based on studies evaluating once-daily vs. twice daily lopinavir/ritonavir (LPV/r) regimens

Authors: R Qaqish, J van Wyk and MS King

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P58

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice

Authors: JM Llibre, E Martínez, P Barreiro, R Escrig, E Ribera, M Cervantes, A Imaz, F Gutierrez, H Knobel, A Ornelas, FX Zamora and B Clotet

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P35

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach

Authors: A Grant, Y Kamuntu, P Read and R Kulasegaram

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P33

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study

Authors: L Schneider, A Houssaini, S Lambert, G Peytavin, R Agher, A Chermak, P Flandre, V Calvez, AG Marcelin, J Ghosn and C Katlama

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P29

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Darunavir in experienced patients

Authors: G Sterrantino, B Borchi, M Trotta, D Bartolozzi and F Leoncini

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P27

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
0231. Growing old with HIV — dealing with co-morbidities

Authors: W Powderly

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O25

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
0222. Major issues and their solutions in the management of HIV and TB — from the laboratory to the patient and population

Authors: M Schechter

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O23

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O213. Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial

Authors: N Clumeck, JR Arribas, P Pulick, G Fätkenheuer, A Hill, Y Van Delft and C Moecklinghoff

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O19

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Epidemiological features, therapeutic strategies and long-term immunological outcomes in virologically suppressed HIV+ very late presenters

Authors: L Martinelli, D Francisci, A Sgrelli and F Baldelli

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P19

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O211. The state of PI monotherapy and NRTI-sparing therapy

Authors: JR Arribas

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O17

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O134. HIV treatment as prevention — human rights issues

Authors: J Amon

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O15

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data

Authors: E DeJesus, A Mills, L Bhatti, C Conner and S Storfer

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P4

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O114. Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection

Authors: S Lodi, C Kücherer, AM Bakken Kran, B Masquelier, A d'Arminio Monforte, J Gill, D Dunn, D Pillay and K Porter

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O4

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
The management of acute retroviral syndrome

Authors: A Hristea, R Petre, S Gliga, I Olaru, M Ion, R Moroti, C Popescu, R Mihailescu, M Radulescu and V Arama

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P2

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O112. International perspectives on adherence and resistance to HIV antiretroviral therapy

Authors: D Bangsberg

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O2

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Journal of the International AIDS Society